MMP9, known as gelatinase B, promotes the degradation of an important component of the basal membrane, type IV collagen, which is crucial for the invasion of malignant tumors from the proteolysis of ECM with CRC progression and metastasis [40]. The gene discussed is MMP9; the disease is cancer.